These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. Forlenza OV; De-Paula VJ; Diniz BS ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396 [TBL] [Abstract][Full Text] [Related]
4. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection. Rametti A; Esclaire F; Yardin C; Cogné N; Terro F Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787 [TBL] [Abstract][Full Text] [Related]
5. Lithium, a potential protective drug in Alzheimer's disease. Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403 [TBL] [Abstract][Full Text] [Related]
6. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737 [TBL] [Abstract][Full Text] [Related]
7. A new avenue for lithium: intervention in traumatic brain injury. Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257 [TBL] [Abstract][Full Text] [Related]
8. Reducing the progression of Alzheimer's disease in Down syndrome patients with micro-dose lithium. Priebe GA; Kanzawa MM Med Hypotheses; 2020 Apr; 137():109573. PubMed ID: 31986471 [TBL] [Abstract][Full Text] [Related]
9. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease. Yeh HL; Tsai SJ Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542 [TBL] [Abstract][Full Text] [Related]
10. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy. Damri O; Shemesh N; Agam G Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448 [TBL] [Abstract][Full Text] [Related]
11. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Forlenza OV; Torres CA; Talib LL; de Paula VJ; Joaquim HP; Diniz BS; Gattaz WF J Psychiatr Res; 2011 Feb; 45(2):220-4. PubMed ID: 20576277 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium. Singulani MP; De Paula VJR; Forlenza OV Neurosci Lett; 2021 Aug; 760():136078. PubMed ID: 34161823 [TBL] [Abstract][Full Text] [Related]
13. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. Camins A; Verdaguer E; Junyent F; Yeste-Velasco M; Pelegrí C; Vilaplana J; Pallás M CNS Neurosci Ther; 2009; 15(4):333-44. PubMed ID: 19889130 [TBL] [Abstract][Full Text] [Related]
14. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. Leyhe T; Eschweiler GW; Stransky E; Gasser T; Annas P; Basun H; Laske C J Alzheimers Dis; 2009; 16(3):649-56. PubMed ID: 19276559 [TBL] [Abstract][Full Text] [Related]
15. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Forlenza OV; Radanovic M; Talib LL; Gattaz WF Br J Psychiatry; 2019 Nov; 215(5):668-674. PubMed ID: 30947755 [TBL] [Abstract][Full Text] [Related]
17. Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model. Zhao L; Gong N; Liu M; Pan X; Sang S; Sun X; Yu Z; Fang Q; Zhao N; Fei G; Jin L; Zhong C; Xu T Neurobiol Aging; 2014 Dec; 35(12):2736-2745. PubMed ID: 25018109 [TBL] [Abstract][Full Text] [Related]
18. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice. Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765 [TBL] [Abstract][Full Text] [Related]
19. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease. Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479 [TBL] [Abstract][Full Text] [Related]
20. Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease. Straten G; Saur R; Laske C; Gasser T; Annas P; Basun H; Leyhe T Curr Alzheimer Res; 2011 Dec; 8(8):853-9. PubMed ID: 21875410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]